Literature DB >> 15454107

Increased bone density associated with DLX3 mutation in the tricho-dento-osseous syndrome.

Ryan J Haldeman1, Lyndon F Cooper, Thomas C Hart, Ceib Phillips, Courtney Boyd, Gayle E Lester, J Timothy Wright.   

Abstract

Tricho-dento-osseous syndrome (TDO) (OMIM #190320) is an autosomal dominant disorder characterized and named for the three most commonly affected tissues hair, teeth, and bones. Common to all individuals with TDO studied to date is a four base-pair deletion in the DLX3 gene on chromosome 17q21. This mutation is associated with a variable bone phenotype that includes alteration in intramembranous bone formation in the skull. The purpose of this study was to characterize and compare endochondral bone phenotypes and variability at central and peripheral locations of the skeleton by evaluating bone density in individuals having the same DLX3, 4 bp DEL,NT3198 mutation (OMIM 600525) and non-affected family members using dual-energy x-ray absorptiometry (DEXA). Thirty-four individuals (20 TDO-affected and 14 non-affected) participated in this prospective study. All participants were evaluated for the DLX3 mutation associated with TDO. All subjects received DEXA scans at common, literature-supported osteoporotic test regions including: (1) non-dominant distal radius/ulna, (2) femoral neck, and (3) lumbar spine L2-4. There was a significant increase (P < 0.05) in bone mineral density in TDO-affected individuals compared with control individuals at each test region. The markedly increased bone density in individuals having the DLX3, 4 bp DEL,NT3198 mutation shows that this alteration affects both endochondral and intramembranous bone formation and suggests that the DLX3 gene is important in bone formation and/or homeostasis of the appendicular skeleton.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15454107     DOI: 10.1016/j.bone.2004.06.003

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  15 in total

Review 1.  Dlx genes, p63, and ectodermal dysplasias.

Authors:  Maria I Morasso; Nadezda Radoja
Journal:  Birth Defects Res C Embryo Today       Date:  2005-09

2.  A 4 bp deletion mutation in DLX3 enhances osteoblastic differentiation and bone formation in vitro.

Authors:  Sun Jin Choi; In Sun Song; Ok Hee Ryu; Sung Won Choi; P Suzanne Hart; Wells W Wu; Rong-Fong Shen; Thomas C Hart
Journal:  Bone       Date:  2007-09-19       Impact factor: 4.398

Review 3.  Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse.

Authors:  Qing Xiong; Yan Jiao; Karen A Hasty; S Terry Canale; John M Stuart; Wesley G Beamer; Hong-Wen Deng; David Baylink; Weikuan Gu
Journal:  Genomics       Date:  2009-01-14       Impact factor: 5.736

4.  Dlx genes and the maintenance of bone homeostasis and skeletal integrity.

Authors:  G Levi; Y Gitton
Journal:  Cell Death Differ       Date:  2014-09       Impact factor: 15.828

5.  MicroRNA 665 Regulates Dentinogenesis through MicroRNA-Mediated Silencing and Epigenetic Mechanisms.

Authors:  Hannah M Heair; Austin G Kemper; Bhaskar Roy; Helena B Lopes; Harunur Rashid; John C Clarke; Lubana K Afreen; Emanuela P Ferraz; Eddy Kim; Amjad Javed; Marcio M Beloti; Mary MacDougall; Mohammad Q Hassan
Journal:  Mol Cell Biol       Date:  2015-06-29       Impact factor: 4.272

Review 6.  Reassessing the Dlx code: the genetic regulation of branchial arch skeletal pattern and development.

Authors:  Michael J Depew; Carol A Simpson; Maria Morasso; John L R Rubenstein
Journal:  J Anat       Date:  2005-11       Impact factor: 2.610

7.  In vivo impact of a 4 bp deletion mutation in the DLX3 gene on bone development.

Authors:  S J Choi; G D Roodman; J Q Feng; I S Song; K Amin; P S Hart; J T Wright; N Haruyama; T C Hart
Journal:  Dev Biol       Date:  2008-10-25       Impact factor: 3.582

8.  Expression and function of Dlx genes in the osteoblast lineage.

Authors:  Haitao Li; Inga Marijanovic; Mark S Kronenberg; Ivana Erceg; Mary Louise Stover; Dimitrios Velonis; Mina Mina; Jelica Gluhak Heinrich; Stephen E Harris; William B Upholt; Ivo Kalajzic; Alexander C Lichtler
Journal:  Dev Biol       Date:  2008-01-16       Impact factor: 3.582

9.  Molecular consequences of a frameshifted DLX3 mutant leading to Tricho-Dento-Osseous syndrome.

Authors:  Olivier Duverger; Delia Lee; Mohammad Q Hassan; Susie X Chen; Frederic Jaisser; Jane B Lian; Maria I Morasso
Journal:  J Biol Chem       Date:  2008-05-19       Impact factor: 5.157

10.  DLX3 regulates bone mass by targeting genes supporting osteoblast differentiation and mineral homeostasis in vivo.

Authors:  J Isaac; J Erthal; J Gordon; O Duverger; H-W Sun; A C Lichtler; G S Stein; J B Lian; M I Morasso
Journal:  Cell Death Differ       Date:  2014-06-20       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.